A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors - Concepedia

Concepedia

Publication | Open Access

A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors

DOI Full Paper Access

86

Citations

10

References

2011

Year

Daruka Mahadevan, Ruth Plummer, Matthew Squires, Diane Rensvold, Sandra Kurtin, Chris Pretzinger, Tomislav Dragovich, Joëlla W. Adams, Victoria Lock, Donna-Michelle Smith,

Annals of Oncology

Pharmacodynamic StudyOncologyMedicinePharmacotherapyRefractory Solid TumorsCyclin-dependent Kinase InhibitorCancer TreatmentAnti-cancer AgentPharmacologyRadiation Oncology

References

	Year	Citations

Page 1

Page 1